chrisvoncsefalvay/vaers-outcomes huggingface dataset:
recently tested positive for Covid; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (recently tested positive for Covid) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (recently tested positive for Covid). At the time of the report, COVID-19 (recently tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication was reported.  Reported that patient had chills and a cough for 3 days and was horribly tired after getting a Covid-19 Vaccine.  No treatment information was reported.  Company comment: This is a spontaneous case concerning a female patient of unknown age, with no reported medical and vaccination history. Patient experienced the unexpected non-serious AESI event of Covid-19. On unknown date, the patient received unspecified product of Covid-19 vaccine. On unknown date, patient was tested positive for Covid-19. It was reported that the patient had chills and cough for 3 days and was horribly tired after the patient received the unspecified product of Covid-19 vaccine. No other information surrounding the event was reported. The outcome of the event was unknown. The current Covid-19 pandemic remain confounder for the event Covid-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-608760 (E2B Linked Report).; Sender's Comments: This is a spontaneous case concerning a female patient of unknown age, with no reported medical and vaccination history. Patient experienced the unexpected non-serious AESI event of Covid-19. On unknown date, the patient received unspecified product of Covid-19 vaccine. On unknown date, patient was tested positive for Covid-19. It was reported that the patient had chills and cough for 3 days and was horribly tired after the patient received the unspecified product of Covid-19 vaccine. No other information surrounding the event was reported. The outcome of the event was unknown. The current Covid-19 pandemic remain confounder for the event Covid-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. US-MODERNATX, INC.-MOD-2022-608760:Case Crosslinked with MOD22-018820,MOD22-019092 (Husband case)
Fever; This non-serious case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24-APR-2023, the patient received the 2nd dose of Shingrix. On 24-APR-2023, less than a day after receiving Shingrix, the patient experienced fever (Verbatim: Fever). The outcome of the fever was not resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.     It was unknown if the company considered the fever to be related to Shingrix.   Additional Information: GSK Receipt Date: 02-MAY-2023 The reporter was husband of patient who reported that patient received dose of Shingrix. and developed a high fever that evening.  The fever subsided after a few days, but seemed to had never completely resolved.  The patient still had a one degree or so fever at the time of reporting. The reporter declined to provide any of their or the patient's information. All information provided was reported. The reporter did not consent to follow up.
localized erythema & edema @ inj site of vax 9SEP97;resolving 11SEP97;
My PSA, Total, count increased by 3.4 ng/mL after receiving the Moderna vaccine  Went from 5.1 pre-shot to 8.5 post dose.
pt is a 36 year old male witg hx of cardiac arrythmias  pt had received his 1st pfizer vaccine left deltoid at 10:32 am and was sent into observation area. pt approached this writer about 10:34 and reported he felt a rapid heart rate EMT was nearby and was notified. EMT escorted pt to a seated/screened area to obtain vitals and EKG, MD was made aware and was present. 142/87, pulse ox 98 pulse 109. pt had denied any chest pain,shortness of breath,  nausea or dizziness. pt denies any medications and reports this happened before in the past and he was seen by his doctor and on no medication and that he had rapid heart rate about 1 month and did not follow up with his MD. MD.10:39 118/72 pulse ox 99 pulse 115. pt denies any other symptoms writer remained with patient in screened area for observation 11:am 118/72, pulse 69, pulse ox 99, 11:10 , 136/77, 77 pulse, 99 pulse ox. pt was  given water, PO and recommended to follow up with his PCP. emt offered pt option to be taken to ER for further evaluation and patient refused offer. pt is educated to make staff aware of this event upon arriving for his second injection.pt left on his own insistence and was in no distress and reported " feeling better"and denied any rapid heart rate, shortness of breath, dizziness, chest pain or nausea.pt was observed for 30 mns , seen by MD and EMT prior to leaving.
On 3/12/09 Pt presented here with vesicular like lesions to tip of nose and another vesicular like area with redness to left side of nose. Normal eye and facial exam. Cultures taken with rupture of one vesicle discussed with Opth to confirm that eye only needs TX if SX's develop. Tx: 1) Valtrex tab 1GM q 8hrs X 7 days 2) Zovirax Top Ointment 5% q 3h topically 7 days 3) Keflex 500mg QID 10 days.
This spontaneous report as received from a consumer reporting on himself: a 92 years old male patient. The patient's medical history included shingles outbreak, from which he recovered approximately in June 2013. He had no concomitant medications and no drug reactions/allergies. On an unspecified date in December 2013 (reported as 6 months ago), 6 months after recovering from shingles outbreak, the patient was vaccinated with a dose of ZOSTAVAX, subcutaneously, injection site, lot#, expiration date not reported. On an unspecified date in approximately December 2013 (reported as "3-4 days after getting the vaccine") the patient started experiencing continuous itching sensations in his upper back area across the upper 3rd of his back from side to side. The reported explained that the area was red but did not look like a rash and mildly painful. The patient stated that his adverse effect reaction was much milder than what he had expected with his previous shingles breakout. The patient did not seek medical attention but reportedly was treated with OTC (over the counter) creams that have not been effective and "countless other medicines". No lab diagnostic studies were performed. The outcome of the adverse effects was reported as not recovered/not resolved. Relatedness between use of ZOSTAVAX and the reported adverse effects was unknown Additional information has been requested.
Patient was administered undiluted dose of Pfizer Vaccine, Provider contacted parents and notified. No adverse s/sx assessed at this time. Provider educated parents on s/sx to watch for and provided clinic nurse triage number for questions or concerns.
Information has been received from a lawyer regarding a case in litigation concerning a 71 year old female patient. The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster related conditions. In 2014 the patient was administered ZOSTAVAX, (lot# and route unknown), by a healthcare provider at a pharmacy. On or about 16-JAN-2017, the patient was treated by a healthcare provider at a hospital for shingles as a result of vaccination with ZOSTAVAX. The patient claimed damages as a result of: injury to herself; loss of consortium, loss of services and economic losses. Additional information has been requested.
This spontaneous report as received from a physician refers to unspecified number of patients of unknown demographics. On an unknown date, an unspecified number of patients may have received ROTATEQ 0.5 millilitres suspension, orally (Lot# J001252, expiry date: 20-SEP-2014). The reporter reported that ROTATEQ were exposed to a lowest temperature of 32F (Fahrenheit) for a total of 1 hour over "four different occasions" and the improperly stored ROTATEQ were administered orally to an unspecified amount of patients. No adverse effect was reported. There was no product quality complaint involved. The case is linked to 1405USA004024, 1405USA011937, 1405USA011938, 1405USA009508, 1405USA011939, 1406USA009955, 1406USA009970, 1406USA009971, 1406USA009973, 1406USA009974, 1406USA009977 and 1406USA009978 (same reporter link). Additional information has been requested.
FLU-TYPE SYMPTOMS; BODY ACHES & PAINS, EXTREMELY COLD - EVENTUALLY TURNING TO EXCESSIVELY HOT/SWEATS - REPEAT, SEVERE HEADACHE, NAUSEA, FAINT,  IT LASTED UNTIL AROUND 1:00 P.M. THE FOLLOWING DAY, TUESDAY, FEBRUARY 18, 2020
Rash on limbs.  Saw PCP. Taking PO Benadryl, and doubled Zyrtec
I have allergies and it feels like allergic hypersensitivity, which I had before when my allergy shots were missed a year or so ago.    Burning and tingling feeling in legs, torso, neck basically where clothes touches or rubs. Some tingling sensation on tongue as well. I stayed after 20 minutes after the vaccine because of I have allergies.  After I left and got into my car to drive away I started having the burning feeling in my legs, torso and tingling in lips and tongue.  I work for the ED group, so I drove over and stayed by the entrance until I felt like it was not getting any worse.  I waited for about an hour.    I though the burning sensation would go away, but it has not.  I called my allergist and he advised I should contact you and report via this source.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 61 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Dec2021 10:45 (Lot number: FG3527) at the age of 61 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER2613, Location of injection: Arm Left, Vaccine Administration Time: 08:00 AM), administration date: 17Mar2021, when the patient was 61 years old, for COVID-19 Immunisation; Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0150, Location of injection: Arm Left, Vaccine Administration Time: 08:00 AM), administration date: 07Apr2021, when the patient was 61 years old, for COVID-19 Immunisation, reaction(s): "Rash on left Arm around shot". The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021 10:45, outcome "unknown", described as "Dose Number=03"; NAUSEA (non-serious) with onset 02Dec2021 12:45, outcome "recovered" (03Dec2021 18:00), described as "Nausea"; INFLUENZA LIKE ILLNESS (non-serious) with onset 03Dec2021 02:30, outcome "recovered" (03Dec2021 18:00), described as "flu like"; PAIN (non-serious) with onset 03Dec2021 02:30, outcome "recovered" (03Dec2021 18:00), described as "body aches"; HEADACHE (non-serious) with onset 03Dec2021 02:30, outcome "recovered" (03Dec2021 18:00), described as "headache". Therapeutic measures were not taken as a result of nausea, influenza like illness, pain, headache. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Hospitalization Prolonged: No known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The device Date was 06Dec2021. No follow-up attempts are possible. No further information is expected.
diarrhea for >15days and still continuing. vomiting, spotty bloody stool, stool is being cultured. irritable crying. unable to sleep. no x ray done yet. blood drawn today 4.12.7 to do further test.
Information has been received from a physician concerning a 2 year old child who was vaccinated with the first dose of hep b vaccine recombinant. Subsequently the pt developed hives. It was reported that the rash resolved on it's own. Additional info has been requested.
Body aches; Fatigue; Little headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), FATIGUE (Fatigue) and HEADACHE (Little headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced MYALGIA (Body aches), FATIGUE (Fatigue) and HEADACHE (Little headache). On 07-May-2021, MYALGIA (Body aches), FATIGUE (Fatigue) and HEADACHE (Little headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Treatment information for the event was provided.   This case was linked to MOD-2021-239829 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jun-2021 and was forwarded to Moderna on 28-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), FATIGUE (Fatigue) and HEADACHE (Little headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced MYALGIA (Body aches), FATIGUE (Fatigue) and HEADACHE (Little headache). On 07-May-2021, MYALGIA (Body aches), FATIGUE (Fatigue) and HEADACHE (Little headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Treatment information for the event was provided.   This case was linked to MOD-2021-239829 (Patient Link).
they've also experienced teeth sensitivity to hot and cold temperatures; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 59 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERAESTHESIA TEETH (non-serious), outcome "unknown", described as "they've also experienced teeth sensitivity to hot and cold temperatures".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101771853 Same reporter/drug, different patients.;US-PFIZER INC-202101767836 Same reporter/drug, different patients.
Fever 102°, and loss of appetite, fatigue, joint pain (shoulders, knees, hands, feet, ankles), backache, persistent headache, soreness around injection site. Fever lasted 2 days, all other symptoms persisted 4-5 days. Missed entire week of work due to employer policy about fever.
I am a new immunizations nurse. I reconstituted this vaccine with regular diluant, not realizing that there was a liquid component.
9 days after MMR, Varivax, Urticaria for 2 weeks, no ill, no new foals, no meds.
Fatigue, Increased heart rate, Nausea, Vomiting, Headache
tingling in her knees and arms; she's just been in bed Friday, Saturday, Sunday, until now; wet the bed; had no control of her bladder; a lot of pain in her legs and her arms; severe headache; normal, kind of sick, in bed; like she had the flu; This spontaneous case was reported by a consumer and describes the occurrence of ENURESIS (wet the bed), URINARY INCONTINENCE (had no control of her bladder), PAIN IN EXTREMITY (a lot of pain in her legs and her arms), PARAESTHESIA (tingling in her knees and arms) and BEDRIDDEN (she's just been in bed Friday, Saturday, Sunday, until now) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stroke (History of stroke 10 or 11 years ago). Concurrent medical conditions included Protein S deficiency.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Aug-2021, the patient experienced ILLNESS (normal, kind of sick, in bed) and INFLUENZA LIKE ILLNESS (like she had the flu). On 19-Aug-2021, the patient experienced ENURESIS (wet the bed), URINARY INCONTINENCE (had no control of her bladder), PAIN IN EXTREMITY (a lot of pain in her legs and her arms) and HEADACHE (severe headache). On 20-Aug-2021, the patient experienced BEDRIDDEN (she's just been in bed Friday, Saturday, Sunday, until now). On an unknown date, the patient experienced PARAESTHESIA (tingling in her knees and arms). On 16-Aug-2021, ILLNESS (normal, kind of sick, in bed) and INFLUENZA LIKE ILLNESS (like she had the flu) had resolved. On 23-Aug-2021, BEDRIDDEN (she's just been in bed Friday, Saturday, Sunday, until now) had resolved. At the time of the report, ENURESIS (wet the bed), URINARY INCONTINENCE (had no control of her bladder), PAIN IN EXTREMITY (a lot of pain in her legs and her arms), PARAESTHESIA (tingling in her knees and arms) and HEADACHE (severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.  On Friday 20-Aug-2021, patient went to see her doctor and took a UTI test, but it was negative. Patient went to urgent care later that day on 20-Aug-2021 and got a blood draw. The results have not come back yet as of 23-Aug-2021.
WHEN DELIVERING IMMUNIZTION TO PEDIATIRC PATIENT, PATIENT MOVED AS IMMIZATION WAS INSIDE DELTOID. CASING SOME OF THE IMMUNZTION TO SPILL OUT. NOT ALL OF DOSE WAS ADMINISTERED. 0.15ML OF DOSE REMAINED. DIPSOSED OF USED NEEDLE PROPRELY STAFF ADMINISTERED NEW PEDIATIRC DOSE SUCCESFULLY.
At 4 months, child noted to be "grayish; unresponsive and limp" for about 1 1/2 to 2 minutes, post vax, earlier that day (about 3-5 hours).
VARIVAX vaccine dose # 1 was given SQ on right arm at 11:10 AM on 2/6/12. At 11:15 AM redness at injection site and both cheeks were noticed. BENADRYL 0.2 mL was given IM at 11:20 AM. At 11:50 AM redness at injection site has decreasing. Patient is alert, no signs of distress, and d/c to home with parents.
Fainted about a minute after receiving vaccination. Nothing major, just want to make sure it is known in case related to lot or similar.
S/P pfizer vaccination for COVID-19 about 6 weeks ago with progressive confusion,  new fevers and encephalitis with parkinsonism Appears to be consistent with inflammatory encephalitis
Initial report received on 09 December 2009 from a patient's parent. A 3-year-old male patient had received a first intramuscular deltoid injection of FLUZONE No Preservative 2009-2010 (lot number UT3173G) on 21 October 2009. The patient had no concurrent illnesses at the time. Medical history includes acute respiratory distress, and possibly asthma. The patient has never received a measles mumps rubella vaccine, and additionally has not received any other vaccines in 2009. Approximately 10 days after receiving the FLUZONE vaccine, the patient developed head thrashing, facial twitching and hand to face rubbing. The patient was to be evaluated on 09 December 2009 by pediatric neurology for worsened symptoms. At the time of this report, the patient had not recovered. Documents held by sender: None.
approx. 5 mins after receiving vaccine, patient began complaining of weakness, lightheadedness, and right arm tingling. Patient was clammy
Hearing people chattering in my ears 2 days after the vaccine; not recognizing where I am; feeling foggy; This is a spontaneous report from a contactable consumer. This female Consumer reported for herself that an elderly female patient  (Age: 91, unit: unknown) received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 28Feb2021 10:30 am (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  Medical history included hypertension, hard of hearing, colitis, patient had Covid prior vaccination. There were no concomitant medications.  The patient previously took iodine and experienced allergies.  The patient experienced hearing people chattering in her ears 2 days after the vaccine. Also feeling foggy and not recognizing where she was on 02Mar2021 with outcome of not recovered. The event result in Doctor or other healthcare professional office/clinic visit. Patient was not pregnant. No other vaccine in four weeks. No treatment received for events. The Covid was not tested post vaccination.  Information about the Lot/batch number has been requested.
I had common side effects including fever of 102.7, joint pain, body aches, headache, stomach pain  from the evening of 4/3/21 until today, 4/6/21. The fever has fluctuated from no fever to102.7, to lower grade 99.1 to 100.5 to no fever to lower grade, 99.1 over the course of that time. The reason for my VAERS report is the major rash that I developed on the evening of 4/5/21 that covers my entire back, my chest, and up to the first two inches of my neck. I contacted my physician practice right away, and recommended that I take Benadryl every few hours. This morning, the surface area of the rash remains the same as yesterday, but is a much lighter hue. Yesterday was deep red and felt very hot. Today, is more of a pinkish red. Today my back feels as if I have a bad sunburn. Clothing touching my back causes a discomfort similar to sunburn. Parts of my back also now have white dryness lines/wrinkles.
Patient stated that she had fever, chills, extreme itching at site of injection, itchy throat and short of breath.